Harbin Taihua Pharmaceutical

Harbin Taihua Pharmaceutical is a Chinese pharmaceutical enterprise focused on the development and production of Traditional Chinese Medicine (TCM) and chemical drugs. Based in Harbin, the company maintains a diverse portfolio that includes treatments for cardiovascular, respiratory, and digestive conditions. Their operations encompass the entire value chain from research and development to large-scale GMP-certified manufacturing of various dosage forms such as tablets and injections. Harbin Taihua is recognized for its integration of modern pharmaceutical technology with traditional herbal formulations. The company primarily serves the healthcare market within China and produces several key active pharmaceutical ingredients. It was listed on the National Equities Exchange and Quotations (NEEQ) in 2016, reflecting its established position in the regional pharmaceutical industry.